HOPA News Spring 2026

Cover Story

AL Amyloidosis: When Small Proteins Cause Big Problems

With the need to figure out how to treat AL amyloidosis in the relapsed setting, novel therapies are moving away from suppressing the plasma cell clone to creating therapies that target the removal of existing amyloid deposits.

Read Article

A large plasma cell looming over a city in purple

An image of Non-Hodgkin's lymphoma cells

Clinical Controversies

First-Line Treatment for Mantle Cell Lymphoma: In with Bruton Tyrosine Kinase Inhibitors and Out with Transplant?

Read Article

An image of a cancer cell and lungs in red

Feature

IMforte and DeLLphi-304: Small But Significant Improvements in the Treatment of ES-SCLC

Read Article

Personal Reflection

On Mentoring the Next Generation of Oncology Pharmacists

Read Article

Clinical Pearls

Balancing Rejection and Remission: Immune Checkpoint Inhibitors in Solid Organ Transplant

Read Article

Time To Talk: Clinical Trials

Learn how clinical trials help turn hope into outcomes with HOPA's Time To Talk: Clinical Trials, an initiative providing resources about advanced cancer treatment options.

The People Behind the Mission

Read Article

The Resident's Cubicle

Collaborative Excellence in Oncology Pharmacy: A Residency Director's Perspective on Building Interdisciplinary Skills

Read Article

Quality

Pharmacist Contributions to Quality Improvement in Oncology Care: 2025 ASCO Quality Care Symposium

Read Article

A group of doctors and pharmacists and nurses talking

Practice Management

Leveraging Integrated Specialty Pharmacy Programs to Optimize Oncology Practice Management

Read Article

An image of a dirt road through a field with the sun shining on the other side

Focus on Patient Care

Does Anybody Have a Map? Navigating the Unmarked Dirt Roads of the Healthcare System

Read Article

HOPA staff and leadership posed with a large ASCO sign

Member's Research

Advancing Oral Oncolytic Care: HOPA and ASCO Partner to Standardize Quality Improvement in Oral Anticancer Agent Programs

Read Article

Robert Mancini speaking at HOPA 2026 while holding a copy of the HOPA Book of Letters

HOPA News Spring 2026

AL Amyloidosis: When Small Proteins Cause Big Problems

First-Line Treatment for Mantle Cell Lymphoma: In with Bruton Tyrosine Kinase Inhibitors and Out with Transplant?

IMforte and DeLLphi-304: Small But Significant Improvements in the Treatment of ES-SCLC

On Mentoring the Next Generation of Oncology Pharmacists

Balancing Rejection and Remission: Immune Checkpoint Inhibitors in Solid Organ Transplant

Time To Talk: Clinical Trials

The People Behind the Mission

Collaborative Excellence in Oncology Pharmacy: A Residency Director's Perspective on Building Interdisciplinary Skills

Pharmacist Contributions to Quality Improvement in Oncology Care: 2025 ASCO Quality Care Symposium

Leveraging Integrated Specialty Pharmacy Programs to Optimize Oncology Practice Management

Does Anybody Have a Map? Navigating the Unmarked Dirt Roads of the Healthcare System

Advancing Oral Oncolytic Care: HOPA and ASCO Partner to Standardize Quality Improvement in Oral Anticancer Agent Programs

The Many Achievements of the Oncology Pharmacy Community

Explore more from HOPA News